SCHEMBL1633858

SCHEMBL1633858

CC(C)N1CCC(Oc2cccc3cnc(Nc4ccc(S(=O)(=O)N5CCOCC5)cc4)nc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.49
JAK1 P23458 2/20 0.49
TYK2 P29597 2/20 0.49
JAK3 P52333 2/20 0.49
MERTK Q12866 4/20 0.45
AXL P30530 2/20 0.45
TYRO3 Q06418 2/20 0.45
TNIK Q9UKE5 1/20 0.45
CDK2 P24941 4/20 0.44
CCNT1 O60563 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK9 P50750 1/20 0.44
CCNA1 P78396 1/20 0.44
IGF1R P08069 1/20 0.44
CCNE1 P24864 3/20 0.43
CDK1 P06493 2/20 0.43
CDK4 P11802 2/20 0.43
CCNB1 P14635 2/20 0.43
CCND1 P24385 2/20 0.43
MCHR1 Q99705 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12724051 0.92 JAK2 (0.48) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1633848 0.87 JAK2 (0.60) JAK2JAK1TYK2JAK3MERTK
SCHEMBL1632073 0.87 CDK4 (0.57) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1631022 0.86 JAK2 (0.54) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1633947 0.85 MAPK10 (0.58) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1633043 0.83 JAK2 (0.55) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1634187 0.83 JAK2 (0.57) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1632322 0.83 HRH3 (0.47) MERTKAXLTYRO3CDK2CCNT1
SCHEMBL1632549 0.82 JAK2 (0.54) JAK2JAK1TYK2JAK3TNIK
SCHEMBL12724803 0.82 JAK1 (0.57) JAK2JAK1TYK2JAK3TNIK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed